Get Compensation With a Xeljanz Lawsuit The drug Xeljanz, a popular choice for individuals suffering from psoriatic and rheumatoid arthritis as well as ulcerative colitis, now sports a warning label from the Food and Drug Administration (FDA). The label, added in 2019, warns consumers that Xeljanz may increase a person’s risk of developing blood clots. […]
The drug Xeljanz, a popular choice for individuals suffering from psoriatic and rheumatoid arthritis as well as ulcerative colitis, now sports a warning label from the Food and Drug Administration (FDA). The label, added in 2019, warns consumers that Xeljanz may increase a person’s risk of developing blood clots. Blood clots that form in or travel to the heart, brain or lungs can all be potentially deadly.
The national law firm of Parker Waichman LLP is investigating potential personal injury and wrongful death lawsuits against Pfizer, the maker of Xeljanz. Through our firm’s research and careful review of the FDA’s consumer alerts concerning Xeljanz, our attorneys have discovered that the number of reports of Xeljanz complications is on the rise, suggesting a growing problem with the safety of this class of medications. If you or someone you love has been harmed by this drug, you may have grounds to recover compensation through a Xeljanz thromboembolic injury or fatal lung clot lawsuit. Contact our experienced attorneys today for a free consultation to learn about your legal rights.
Xeljanz and Xeljanz XR are classified as disease-modifying antirheumatic drugs (DMARDs) and are considered Janus kinase (JAK) inhibitors. The dosing for Xeljanz and Xeljanz XR is dependent on the type of condition the drugs are used to treat. As such, one dose may be safe to treat one condition, but that same dose may not be safe to treat another condition. Early results from an ongoing trial show that using Xeljanz and Xeljanz XR can be extremely dangerous in patients with rheumatoid arthritis when patients are given a dose of 10 mg twice daily. The drug trial revealed that patients taking the 10 mg twice daily dosage were at a greater risk of suffering from blood clots or death compared to patients taking a 5 mg twice daily dosage or other drugs to treat rheumatoid arthritis.
Following the alarming results of the Xeljanz and Xeljanz XR post-market study, the FDA required the manufacturer of the drugs to add a black-box warning on the drug label. Black-box warnings are only required when a drug has the potential to cause serious injuries or death.
The warning includes the following language:
The FDA recommends that patients who are at high risk for suffering thrombosis (blood clots) do not take Xeljanz XR or Xeljanz. Risks associated with taking these drugs are potentially very dangerous, and the FDA recommends that they be used in very limited circumstances and for the shortest amount of time possible, regardless of what condition is being treated. Health Canada has issued similar guidance.
Although Xeljanz is being prescribed to patients presently and has been used by doctors for years, the drug’s dangers are only now coming to light. It’s unclear why this is so. Some have pointed the finger at the FDA, claiming that the agency’s process for approving new drugs is inadequate and ineffective for uncovering the hidden dangers of drugs like Xeljanz. In the case of Xeljanz, the drug did proceed successfully through the FDA’s approval process without raising alarm about the potential for blood clots.
Reviewing the FDA’s drug approval process and making the requirements for securing approval more stringent may help reduce the incidence of dangerous side effects from drugs like Xeljanz, as can patients taking a more active role in their own health care by asking their doctors about new drugs they are being prescribed and requesting alternative medications when a drug has not been on the market for long.
Yes. Xeljanz (tofacitinib) is a prescription medication that is classified as a JAK inhibitor. Xeljanz is prescribed to treat patients suffering from the symptoms of psoriatic arthritis, ulcerative colitis, and rheumatoid arthritis. Xeljanz works by hindering overactive Janus kinase proteins within the patient’s body, which reduces symptoms such as inflammation and pain.
The pharmaceutical manufacturer Pfizer manufactures and sells Xeljanz and Xeljanz XR. Pfizer is a publicly traded company with its headquarters in New York City. Xeljanz maker Pfizer is one of the largest pharmaceutical manufacturers in the world.
According to Investors.com, global sales of Xeljanz grew by 30% to $326 million in 2018. Xeljanz sales in the United States increased by 19% in 2018.
There currently isn’t a generic form of Xeljanz available on the market in the United States. Please be mindful that there may be companies online that may attempt to sell potentially unsafe medications marked as a generic equivalent.
The exact price can vary depending on the pharmacy, but without insurance, 5 mg tablets of Xeljanz cost around $4,920 for 60 tablets.
Xeljanz (tofacitinib) can cause dangerous and potentially deadly reactions. The FDA urges patients who are experiencing the following symptoms of a blood clot in their lung(s) to seek immediate emergency medical attention:
Other serious Xeljanz side effects may include high blood pressure, liver damage or gastrointestinal bleeding. If you or a loved one are taking Xeljanz, it’s imperative that you speak with your doctor about these potential risks and dangerous side effects.
The FDA has received numerous reports of thromboembolic injuries linked to patients prescribed Xeljanz and Xeljanz XR. The following are some of the Xeljanz-related injuries, thromboembolic injury events, and fatalities that have been reported:
If you or a loved one has experienced any of these dangerous side effects or if you have lost a loved one due to a thromboembolic event or blood clot brought on by Xeljanz, a lawyer can help you determine whether you have grounds to pursue compensation by filing a legal claim.
At Parker Waichman, our attorneys believe that the victims of injuries caused by this medication deserve justice. If you have been harmed by Xeljanz after being led to believe that it was safe, we may be able to assist you in filing an individual claim or joining a Xeljanz class-action lawsuit. Our firm is at the forefront of product liability litigation, and our attorneys are committed to getting the best results possible for each client.
Each case is different because every Xeljanz claim involves a unique set of circumstances, injuries, and damages. The amount you can recover with the help of a talented Xeljanz lawyer will typically include your medical costs, lost wages, and other economic and non-economic damages.
Also, the knowledge and experience of the law firm representing you can have an impact on your final recovery. At Parker Waichman, our attorneys are skilled litigators, and each case handled by our firm is treated individually and with personalized attention and care. Our defective drug litigation team will fight for your legal rights and work hard to win your case for the full amount of monetary compensation possible.
The process of pursuing justice for you or your loved one’s Xeljanz suffering starts with one short phone call to our office. During your call to our firm, you will speak with a compassionate, caring, and knowledgeable attorney who will review your case, answer your questions, and help you understand your legal options. After that, if we can take your case and you choose to retain us, your dedicated attorney will review your case to determine your legal rights and options for a Xeljanz lawsuit.
With Parker Waichman working on your behalf, you can rest assured that your case is being managed by qualified and experienced legal professionals who care deeply about their clients. Each member of the Parker Waichman team takes pride in our work and will keep you well informed during the progress of your case. At our law firm, you are not a file number; you are a person with real loss, pain, and suffering.
At Parker Waichman, our defective drug attorneys understand how you may feel about filing a product liability lawsuit against a large pharmaceutical company such as Pfizer. But our national law firm has decades of experience going up against big corporations to make them pay for their wrongdoings, so your case will be in good hands. Here are some of the reasons our clients have told us that they chose us:
Parker Waichman has a history of producing near-unprecedented results for our clients and the families of victims throughout the United States. Learn more about our verdicts and settlements and read our client reviews and you’ll soon see that we’re among the top personal injury law firms in the country.
If you or a member of your family suffered dangerous complications while taking Xeljanz or if you lost a loved one as a result of their use of Xeljanz, an attorney from our firm can assist you. Contact Parker Waichman today for a free case review with one of our defective drug injury lawyers by using our live chat or by calling 1-800-YOUR-LAWYER (1-800-968-7529). You’ll be under no obligation, but remember that it’s important not to delay action on your Xeljanz lawsuit, as statutes of limitations will affect the amount of time you have to file your claim.